abstract |
The present invention relates to the use of pyrazolopyrimidine compounds for the production of pharmaceutical compositions for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnkl and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof. |